# Lek Pharmaceuticals – FDA Inspection, Feb 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/lek-pharmaceuticals/86ecc7de-f878-448b-910f-cb7f2cb553f8
Source feed: FDA_Inspections

> FDA inspection 1005712 of Lek Pharmaceuticals, February 24, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005712
- Company Name: Lek Pharmaceuticals
- Inspection Date: 2017-02-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1246916 - 2024-07-26
- FDA Inspection 1254088 - 2023-12-11
- [FDA Inspection 1178973 - 2022-03-18](https://www.keypedia.com/records/fda_inspections/lek-pharmaceuticals/45b6f40d-76b3-4a3a-ba54-df7addeaffc4)
- [FDA Inspection 1045912 - 2018-02-20](https://www.keypedia.com/records/fda_inspections/lek-pharmaceuticals/1c205713-c9e8-42a5-aac4-7e8e5a858fac)
- [FDA Inspection 935159 - 2015-06-30](https://www.keypedia.com/records/fda_inspections/lek-pharmaceuticals/0a8fc7e3-f9f4-434f-878a-68b96987e873)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)

Company: https://www.keypedia.com/companies/lek-pharmaceuticals/6b651b9c-9e4f-46ac-a02a-ddc22f9bc3a6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c